Latest filing published 29 Apr 2025 for Bristol Myers Squibb Co, €178k. Read the official filing
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
This profile gathers the share dealings of Samit Hirawat in Bristol Myers Squibb Co, where the filings describe the role as senior executive. We count 10 filings; the first trade dates from 1 July 2021 and the latest from 25 April 2025.
On the market, this insider has only ever bought: 3 purchases, €365k in total. Open-market purchases are the filings investors watch most closely, because the insider pays for the shares out of pocket. Outside the open market, there are 7 option exercises. Since January 2025: 2 purchases and no sales on the market.
A typical purchase (the median) is worth €96k. The 3 purchases reviewed show no overlap with other insiders buying the same stock within a month.
Most recently, on 29 April 2025, the filings show an open-market purchase worth €178k in Bristol Myers Squibb Co. Typically, a trade is published a median of 4 days after it takes place. US insiders must file a Form 4 within two business days of a trade. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
10 of 10 declarations